Please assess the completion status of the following clinical trial:

Trial Title: Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~-~Subjects must meet all of the following inclusion criteria:~* Age 30-75 years~* LDL-cholesterol = 115 -190 mg/dL~* Triglycerides \< 400 mg/dL~* Any cardiovascular therapy should be stable for type and dose for at least three months~* Signed, written informed consent~Exclusion Criteria:~-~Subjects must meet none of the following exclusion criteria:~* Intolerance to any ingredient of dietary supplement~* Patients already suffering from cardiovascular diseases or at high risk of developing cardiovascular diseases~* Myopathies~* Uncontrolled diabetes mellitus based on PI judgment~* Chronic renal failure \[defined as estimated glomerular filtration rate (eGFR) \<60ml/min/1.73m2\] or liver failure \[defined as aspartate aminotransferase (AST) and /or Alanine Aminotransferase (ALT) \>3 upper limit of normal (ULN)\]~* Body Mass Index \> 32 kg/m2~* Therapy with statins or other drugs or supplements with effects on lipid metabolism~* Patients with acquired immunodeficiency~* Treatment with immunosuppressants~* Pregnant or breastfeeding women~* Women of childbearing potential not willing to use effective birth control methods~* Patients participating or having participated in another clinical trial within the previous 3 months~* Current or recent history of drug or alcohol addiction based on PI judgment

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Nutraceutical combination (Type: EXPERIMENTAL): One film-coated tablet (1300 mg) per os per day to be taken in the evening. Each tablet contains phytosterols 800 mg, Monascus purpureus (167 mg) titrated at 3% in monacolin K (5 mg), niacin 27 mg, linear aliphatic alcohols titrated to 60% octacosanol.
- Placebo (Type: PLACEBO_COMPARATOR): One film-coated tablet (1300 mg) per os per day to be taken in the evening. Placebo tablets identical in appearance, size, shape, weight and taste to the active product.

Based on this trial design, predict the completion outcome and termination type (if applicable).